Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations
- 13 January 2020
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 33 (7), 1287-1297
- https://doi.org/10.1038/s41379-020-0459-6
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Classic lobular neoplasia on core biopsy: a clinical and radio-pathologic correlation study with follow-up excision biopsyLaboratory Investigation, 2013
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samplesNature Biotechnology, 2013
- Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsyCancer, 2012
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- The molecular pathology of breast cancer progressionThe Journal of Pathology, 2010
- Screen‐detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosisHistopathology, 2010
- Breast Cancer Molecular Class ERBB2: Preponderance of Tumors With Apocrine Differentiation and Expression of Basal Phenotype Markers CK5, CK5/6, and EGFRApplied Immunohistochemistry & Molecular Morphology, 2010
- Positioning of necrotic lobular intraepithelial neoplasias (LIN, grade 3) within the sequence of breast carcinoma progressionGenes, Chromosomes and Cancer, 2010
- Genetic and Phenotypic Characteristics of Pleomorphic Lobular Carcinoma In Situ of the BreastThe American Journal of Surgical Pathology, 2009
- Lobular Carcinoma In Situ: A Rare Form of Mammary CancerCA: A Cancer Journal for Clinicians, 1982